Showing 1,801 - 1,820 results of 7,244 for search '"Risk factor"', query time: 0.11s Refine Results
  1. 1801
  2. 1802
  3. 1803
  4. 1804
  5. 1805
  6. 1806
  7. 1807
  8. 1808
  9. 1809
  10. 1810
  11. 1811
  12. 1812
  13. 1813
  14. 1814

    Removal of Expression of Concern for ‘Lipid-lowering therapy in patients with coronary heart disease: an Italian real-life survey. Results from the Survey on Risk FactOrs and CardiovascuLar secondary prevention and drug strategieS (SOFOCLES) in Italy’ by The Monaldi Archives for Chest Disease Editors

    Published 2025-01-01
    “…Results from the Survey on Risk FactOrs and CardiovascuLar secondary prevention and drug strategieS (SOFOCLES) in Italy’ by Caterina Oriana Aragona et al., Monaldi Arch Chest Dis, 2024, Accepted Manuscript, https://doi.org/10.4081/monaldi.2024.2972 IF: 1.1 Q4 NA   The Editors and Publisher of the Monaldi Archives for Chest Disease are publishing this removal of expression of concern to inform readers that the investigation is complete and all earlier issues have been addressed. …”
    Get full text
    Article
  15. 1815
  16. 1816

    Estimation and Correlation of Clinical Significance of Lipoprotein (a) as a Risk Factor of Atherosclerotic Vascular Events in Elderly: A 1-year Cross-sectional Study in KLE’s Dr.... by Yashoda Tushar Maladkar, Veerappa Annasaheb Kothiwale

    Published 2024-12-01
    “…The study aimed to evaluate and correlate the clinical significance of Lp(a) as a risk factor for atherosclerotic vascular events in the elderly population. …”
    Get full text
    Article
  17. 1817
  18. 1818

    The activity of a herbal medicinal product of Phyllanthus niruri and Silybum marianum powdered extracts (Heptex®) in patients with apparent risk factors for nonalcoholic steatohepatitis: a phase II, multicentered, randomized, double-blind, placebo-controlled clinical trial by Mohamed Kamal Shaker, Mohamed Hassany, Basem Eysa, AbdulMoneim Adel, Ahmed Zidan, Shahnaz Mohamed

    Published 2025-01-01
    “…We aimed to investigate the hepatoprotective effect of Heptex® capsules containing 200 mg of Dukung Anak (a powdered extract from aerial parts of Phyllanthus niruri) and 100 mg of Milk Thistle (a powdered extract from fruits of Silybum marianum) in patients with an apparent risk factor for NASH. Methods This was a phase II, randomized, double-blind, placebo-controlled, three-arm, interventional clinical trial. …”
    Get full text
    Article
  19. 1819
  20. 1820